|
Proteintech
ocn Ocn, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc12903609-99-160-166?v=Proteintech Average 96 stars, based on 1 article reviews
ocn - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
|
Merck KGaA
anti-ocn Anti Ocn, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc05847166-75-22-23?v=Merck+KGaA Average 90 stars, based on 1 article reviews
anti-ocn - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
GeneTex
anti -ocn ![]() Anti Ocn, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc09493059-95-4-5?v=GeneTex Average 90 stars, based on 1 article reviews
anti -ocn - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
QED Bioscience
anti-ocn antibody ![]() Anti Ocn Antibody, supplied by QED Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc07353255-65-20-22?v=QED+Bioscience Average 90 stars, based on 1 article reviews
anti-ocn antibody - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ZenBio
anti-osteocalcin (ocn) antibodies cat.#: 614,487 ![]() Anti Osteocalcin (Ocn) Antibodies Cat.#: 614,487, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc11218376-122-12-18?v=ZenBio Average 90 stars, based on 1 article reviews
anti-osteocalcin (ocn) antibodies cat.#: 614,487 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Diagnostic BioSystems
polyclonal anti-rabbit osteocalcin antibody (ocn) ![]() Polyclonal Anti Rabbit Osteocalcin Antibody (Ocn), supplied by Diagnostic BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc10968855-67-27-34?v=Diagnostic+BioSystems Average 90 stars, based on 1 article reviews
polyclonal anti-rabbit osteocalcin antibody (ocn) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
KU Leuven
human specific primary anti-ocn guinea pig antibody ![]() Human Specific Primary Anti Ocn Guinea Pig Antibody, supplied by KU Leuven, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc05355567__mmc1-80-15-29?v=KU+Leuven Average 90 stars, based on 1 article reviews
human specific primary anti-ocn guinea pig antibody - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ImmunoWay Biotechnology Company
anti ocn (1:2000) ![]() Anti Ocn (1:2000), supplied by ImmunoWay Biotechnology Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pm38433534-114-27-46?v=ImmunoWay+Biotechnology+Company Average 90 stars, based on 1 article reviews
anti ocn (1:2000) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
GeneTex
osteogenesis-related proteins ocn gtx64348 ![]() Osteogenesis Related Proteins Ocn Gtx64348, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc09989199-61-0-17?v=GeneTex Average 90 stars, based on 1 article reviews
osteogenesis-related proteins ocn gtx64348 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Bioworld Antibodies
rabbit polyclonal anti-ocn antibody ![]() Rabbit Polyclonal Anti Ocn Antibody, supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pm27607236-127-47-53?v=Bioworld+Antibodies Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-ocn antibody - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
anti-ocn-pe ![]() Anti Ocn Pe, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc06126210-88-7-11?v=Becton+Dickinson Average 90 stars, based on 1 article reviews
anti-ocn-pe - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
anti-ocn-allophycocyanin (apc ![]() Anti Ocn Allophycocyanin (Apc, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+ocn/pmc06126210-87-13-18?v=Becton+Dickinson Average 90 stars, based on 1 article reviews
anti-ocn-allophycocyanin (apc - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Materials Today Bio
Article Title: The combination of a 3D-Printed porous Ti–6Al–4V alloy scaffold and stem cell sheet technology for the construction of biomimetic engineered bone at an ectopic site
doi: 10.1016/j.mtbio.2022.100433
Figure Lengend Snippet: Gene primer sequences for RT‒PCR of BMSCs.
Article Snippet: Primary antibodies, including anti -
Techniques:
Journal: Materials Today Bio
Article Title: The combination of a 3D-Printed porous Ti–6Al–4V alloy scaffold and stem cell sheet technology for the construction of biomimetic engineered bone at an ectopic site
doi: 10.1016/j.mtbio.2022.100433
Figure Lengend Snippet: In vitro analysis of osteogenesis of the combination of BMSCs and PT scaffolds. (A) Schematic of the experiment. BMSCs were collected from each group after 7 days and 14 days of coculturing with PT scaffolds in osteogenic induction medium. (B) Alizarin red staining images. (C) Quantification of Alizarin red staining based on the relative absorbance value. (D–G) The RT‒PCR results of osteogenesis-related gene expression of OCN, OPN, COL-I, and Runx2 in the PT, PT/LC, PT/MC, PT/HC, and PT/CS groups on days 7 and 14. These results suggested that increasing the number of initial seeding cells improved the capability of osteogenic differentiation. (H) Western blot (WB) analysis presented results similar to those of RT‒PCR. ∗ indicates significant differences (p < 0.05).
Article Snippet: Primary antibodies, including anti -
Techniques: In Vitro, Staining, Gene Expression, Western Blot
Journal: Nanomaterials
Article Title: Antibacterial and Osteogenic Activity of Titania Nanotubes Modified with Electrospray-Deposited Tetracycline Nanoparticles
doi: 10.3390/nano10061093
Figure Lengend Snippet: Osteogenic differentiation of osteoblasts on the specimens for 21 d. ( a ) The expression levels of osteopontin (OPN) and osteocalcin (OCN) assessed by real-time RT-PCR (* p < 0.05 vs. MA). ( b ) Fluorescence images of OCN (upper) and OPN (lower) (scale bar = 100 µm).
Article Snippet: To confirm the findings, immunofluorescence staining was performed with solutions of anti-OPN antibody (Santa Cruz Biotechnology, Dallas, TX, USA) and
Techniques: Expressing, Quantitative RT-PCR, Fluorescence
Journal: Journal of Orthopaedic Surgery and Research
Article Title: T. gondii excretory proteins promote the osteogenic differentiation of human bone mesenchymal stem cells via the BMP/Smad signaling pathway
doi: 10.1186/s13018-024-04839-0
Figure Lengend Snippet: TgEP promoted the osteogenic differentiation of hBMSCs. ( A ) Cytotoxic effect of TgEP on hBMSCs detected using a cytotoxicity detection kit. ( B ) Effect of TgEP on cell proliferation assessed using a CCK-8 kit. ( C ) ALP staining was performed to evaluate ALP expression in the cells. Scale bar = 500 μm. ( D ) Quantification of ALP staining results using ImageJ software and statistical analysis. ( E ) Alizarin red staining was performed to measure the content of mineralized nodules in the cells. Scale bar = 500 μm. ( F ) Quantification of alizarin red staining results using ImageJ software and statistical analysis. ( G ) mRNA transcription levels of osteogenic genes were assessed using qRT‒PCR after the cells were treated for 3 or 7 days. ( H , J ) Western blotting analysis of the osteogenic proteins ALP, Runx2, Osx, and OCN in hBMSCs treated for 5 days ( H ) or 7 days ( J ). The expression levels were quantified using β-actin as a loading control ( I , K ). ( L ) Immunofluorescence staining was performed to detect the expression of Runx2 in the cells. Scale bar = 30 μm. (Data are presented as the mean ± SD; n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001, ns P >0.05 compared to the control group)
Article Snippet: For immunohistochemistry analysis, tissue sections were stained according to standard protocols using
Techniques: CCK-8 Assay, Staining, Expressing, Software, Western Blot, Control, Immunofluorescence
Journal: Journal of Orthopaedic Surgery and Research
Article Title: T. gondii excretory proteins promote the osteogenic differentiation of human bone mesenchymal stem cells via the BMP/Smad signaling pathway
doi: 10.1186/s13018-024-04839-0
Figure Lengend Snippet: TgEP promotes the repair of bone defects in vivo. ( A ) Histological analysis of bone tissue sections at 6 weeks, including H&E staining, Masson’s trichrome staining, and osteocalcin immunohistochemical staining. Scale bar = 500 μm. ( B ) Histological analysis of bone tissue sections at 8 weeks, including H&E staining, Masson’s trichrome staining, and osteocalcin immunohistochemical staining. Scale bar = 500 μm.
Article Snippet: For immunohistochemistry analysis, tissue sections were stained according to standard protocols using
Techniques: In Vivo, Staining, Immunohistochemical staining
Journal: Dentistry Journal
Article Title: In Vivo Evaluation of Regenerative Osteogenic Potential Using a Human Demineralized Dentin Matrix for Dental Application
doi: 10.3390/dj12030076
Figure Lengend Snippet: Representative histological images of (H&E) ( A , D , G , J ), Masson’s trichrome ( B , E , H , K ) and osteocalcin immune staining ( C , F , I , L ) are shown at 4 weeks post-treatment. Coronal sections through the mid-point of the defects were prepared from decalcified specimens. Fibrous connective tissues were seen to be mostly filled in the defect areas in the control group ( A – C ). The group treated with SA hydrogel as the only grafted material showing fibrous and adipose tissue ( D – F ). lacuna spaces were observed in the newly formed lamellar bone in NHH with a wide bone marrow space ( G – I ). DDMH-treated groups showed considerable new bone trabeculae formation ( J – L ). BT: bone trabeculae; FT: fibrous tissue. Arrows represent MT- and OCN-positive reactions. Scale bar: 100 μm.
Article Snippet: Subsequently, the samples were embedded in paraffin; and after staining with hematoxylin and eosin (H&E), Masson’s trichrome (MT) (Cat# HT15, Sigma Aldrich), and immunohistochemical staining with a
Techniques: Staining, Control
Journal: Dentistry Journal
Article Title: In Vivo Evaluation of Regenerative Osteogenic Potential Using a Human Demineralized Dentin Matrix for Dental Application
doi: 10.3390/dj12030076
Figure Lengend Snippet: Representative histological images of (H&E) ( A , D , G , J ), Masson’s trichrome ( B , E , H , K ) and osteocalcin immune staining ( C , F , I , L ) are shown at 8 weeks post-treatment. Rather than the newly created bone, the defect locations in the control group were found to be primarily filled with fibrous connective tissues and adipose tissue ( A – C ). Circular new bony islands with the presence of early woven bone were observed in the group treated with SA as the only grafted material ( D – F ). Newly formed lamellar bone was observed in NHH with a wide bone marrow space ( G – I ). In contrast, DDMH-treated groups showed considerable new bone formation at 8 weeks with relatively narrow marrow spaces ( J – L ). BT means bone trabeculae; FT: fibrous tissue. Arrows represent MT- and OCN-positive reactions. Scale bar: 100 μm.
Article Snippet: Subsequently, the samples were embedded in paraffin; and after staining with hematoxylin and eosin (H&E), Masson’s trichrome (MT) (Cat# HT15, Sigma Aldrich), and immunohistochemical staining with a
Techniques: Staining, Control
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: Osteoprogenitors in the bone marrow. The ratio of CD34 + OCN + cells from MDS patients was less than that of normal controls (*P<0.05), and those from Group 2 were great less than that of normal controls (**P<0.01). Data are presented as the mean ± standard deviation. MDS, myelodysplastic syndrome; OCN, osteocalcin; PE, phycoerythrin; PerCP, peridinin chlorophyll.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences) and
Techniques: Standard Deviation
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: Activity of osteoblasts. The percentage of OCN + CD34 − Lin − cells among osteoblasts from MDS patients was less than that of normal controls (*P<0.05). The percentage in Group 1 was close to that of normal controls (P>0.05), whereas the percentage in Group 2 was significantly less than that of normal controls (*P<0.05). Data are presented as the mean ± standard deviation. MDS, myelodysplastic syndrome; OCN, osteocalcin; APC, allophycocyanin; PerCP, peridinin chlorophyll.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences) and
Techniques: Activity Assay, Standard Deviation
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: Correlation between the activity of osteoblasts from MDS patients and the severity of MDS. The percentage of OCN + CD34 − Lin − cells among osteoblasts from MDS patients was negatively correlated with the blast count in bone marrow (P<0.01) and was positively correlated with hemoglobin level (P<0.05) and neutrophil count (P<0.05) in the peripheral blood of the MDS patients. MDS, myelodysplastic syndrome; OCN, osteocalcin.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences) and
Techniques: Activity Assay
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: JAG1 expression on osteoblasts. The percentage of JAG1 + cells out of the total number of OCN + CD34 − Lin − osteoblasts was higher in MDS patients than in normal controls (*P<0.05). Data are presented as the mean ± standard deviation. MDS, myelodysplastic syndrome; OCN, osteocalcin; JAG1, Jagged 1.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences) and
Techniques: Expressing, Standard Deviation
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: TIM3 expression on osteoblasts. The percentage of TIM3 + CD34 + Lin − cells among osteoblasts was higher in MDS patients than in normal controls (*P<0.05). Data are presented as the mean ± standard deviation. MDS, myelodysplastic syndrome; OCN, osteocalcin; TIM3, T-cell immunoglobulin and mucin domain-containing 3.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences) and
Techniques: Expressing, Standard Deviation
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: Osteoprogenitors in the bone marrow. The ratio of CD34 + OCN + cells from MDS patients was less than that of normal controls (*P<0.05), and those from Group 2 were great less than that of normal controls (**P<0.01). Data are presented as the mean ± standard deviation. MDS, myelodysplastic syndrome; OCN, osteocalcin; PE, phycoerythrin; PerCP, peridinin chlorophyll.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences), anti-Lin-FITC (cat. no. 562722 BD Biosciences) and
Techniques: Standard Deviation
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: Activity of osteoblasts. The percentage of OCN + CD34 − Lin − cells among osteoblasts from MDS patients was less than that of normal controls (*P<0.05). The percentage in Group 1 was close to that of normal controls (P>0.05), whereas the percentage in Group 2 was significantly less than that of normal controls (*P<0.05). Data are presented as the mean ± standard deviation. MDS, myelodysplastic syndrome; OCN, osteocalcin; APC, allophycocyanin; PerCP, peridinin chlorophyll.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences), anti-Lin-FITC (cat. no. 562722 BD Biosciences) and
Techniques: Activity Assay, Standard Deviation
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: Correlation between the activity of osteoblasts from MDS patients and the severity of MDS. The percentage of OCN + CD34 − Lin − cells among osteoblasts from MDS patients was negatively correlated with the blast count in bone marrow (P<0.01) and was positively correlated with hemoglobin level (P<0.05) and neutrophil count (P<0.05) in the peripheral blood of the MDS patients. MDS, myelodysplastic syndrome; OCN, osteocalcin.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences), anti-Lin-FITC (cat. no. 562722 BD Biosciences) and
Techniques: Activity Assay
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: JAG1 expression on osteoblasts. The percentage of JAG1 + cells out of the total number of OCN + CD34 − Lin − osteoblasts was higher in MDS patients than in normal controls (*P<0.05). Data are presented as the mean ± standard deviation. MDS, myelodysplastic syndrome; OCN, osteocalcin; JAG1, Jagged 1.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences), anti-Lin-FITC (cat. no. 562722 BD Biosciences) and
Techniques: Expressing, Standard Deviation
Journal: Oncology Letters
Article Title: Abnormal changes in the quantity and function of osteoblasts cultured in vitro in patients with myelodysplastic syndrome
doi: 10.3892/ol.2018.9206
Figure Lengend Snippet: TIM3 expression on osteoblasts. The percentage of TIM3 + CD34 + Lin − cells among osteoblasts was higher in MDS patients than in normal controls (*P<0.05). Data are presented as the mean ± standard deviation. MDS, myelodysplastic syndrome; OCN, osteocalcin; TIM3, T-cell immunoglobulin and mucin domain-containing 3.
Article Snippet: Anti-CD34-PerCP (cat. no. 555823 BD Biosciences), anti-Lin-FITC (cat. no. 562722 BD Biosciences) and
Techniques: Expressing, Standard Deviation